← All trials
NCT03577938
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2018
- Primary completion
- Dec 30, 2020
- Completion date
- Dec 30, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 510
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- People's Liberation Army of ChinaLead sponsor
- Hunan University of Traditional Chinese MedicineOverall official - principal investigator
- Hunan University of Traditional Chinese MedicineCollaborator
- Sun Yat-Sen UniversityCollaborator
- Fudan UniversityOverall official - principal investigator
- Fudan UniversityCollaborator
- Henan Medical UniversityOverall official - principal investigator
- Henan Medical UniversityCollaborator
- China Medical UniversityOverall official - principal investigator
- Capital Medical UniversityOverall official - principal investigator
- Capital Medical UniversityCollaborator
- Huazhong University of Science and TechnologyCollaborator
- Hubei University of Chinese MedicineCollaborator
- People's Liberation Army of ChinaReponsible party - principal investigator
- People's Liberation Army of ChinaStudy chair
- Government of ChinaOverall official - principal investigator
- Fuzhou Infectious HospitalOverall official - principal investigator
- Fuzhou Infectious HospitalCollaborator
- Guangxi Medical UniversityCollaborator
- Hangzhou Xixi hospitalOverall official - principal investigator
- Hangzhou Xixi hospitalCollaborator
- Hepatobiliary Disease Hospital of Jilin Province, Jilin, ChinaCollaborator
- Hubei University of Chinese MedicineOverall official - principal investigator
- Jilin UniversityOverall official - principal investigator
- Shenzhen Third People's HospitalCollaborator
- Shenzhen UniversityCollaborator
- Shenzhen UniversityOverall official - principal investigator
- Shanghai University of Traditional Chinese MedicineCollaborator
- Shanghai University of Traditional Chinese MedicineOverall official - principal investigator
- Xiamen UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.